As the examination of the relationship between WMH and other key biomarkers of AD pathologies was outside the scope of the present study, future work is also still needed to evaluate the temporal and spatial overlap between WMH volume, beta amyloid, and tau pathology and characterize their interplay in contributing to cognitive deterioration. The gene discussed is MAPT; the disease is Alzheimer disease.